GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 45 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $206,000 | -90.5% | 23,902 | -87.7% | 0.09% | -90.6% |
Q2 2019 | $2,167,000 | -16.2% | 194,499 | 0.0% | 0.94% | -38.1% |
Q1 2019 | $2,587,000 | -13.9% | 194,499 | -0.0% | 1.52% | -23.2% |
Q4 2018 | $3,005,000 | +8.5% | 194,500 | 0.0% | 1.98% | -7.6% |
Q3 2018 | $2,770,000 | – | 194,500 | – | 2.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |